protein
| directly interacting with phosphorylated PTK2 (mouse fibroblasts) |
|
Pro-rich domain of TNK1 via its SH3 domain |
|
TRPC3 channels |
|
substrate for parkin (PARK2 deficiency disrupts calcium homeostasis by modulating phospholipase C1 signaling) |
|
association with complexes containing GIT1 and ARHGEF7 is essential for its role in integrin-mediated cell spreading and motility (as a component of this complex, PLCG1 is also involved in the activation of Cdc42 and Rac1) |
|
by regulating the localization of PLCG1, APBB1IP plays a central role in TCR signaling and the transcription of target genes |
|
interacting with NFAT5 (when NaCl is elevated, NFAT5 becomes phosphorylated at Y143, resulting in binding of PLCG1 to that site, which contributes to NFAT5 transcriptional activity, transactivating activity, and nuclear localization) |
|
interacting with NTRK2 (NTRK2-dependent activation of PLCG1 signaling is an important molecular mechanism of limbic epileptogenesis) |
|
CBL is a negative regulator of PLCG1 in endothelial cells |
|
STK11 predominately interacted with LAT and PLCG1 following TCR stimulation |
|
PDPK1 regulates PLCG1 activation in a mechanism involving association of the two enzymes and modulation of PLCG1 tyrosine phosphorylation |
|
interaction of VAV1 with PLCG1 (oncogenic truncation of VAV1 N-terminus elicits conformational changes that interfere with the VAV1-mediated activation of PLCG1 and inhibit calcium mobilization) (PMKID: 22474331) |
|
ITK modulates T-cell signaling by activating PLCG1 and regulating the extent of Ca2+ flux |
|
RASGRF1/2 associates with PLCG1 |
|
a specific docking interaction between the kinase domain of ITK and the C-terminal Src homology 2 (SH2C) domain of PLCG1 that promotes substrate specificity for this enzyme/substrate pair |
|
SOCS7 interact with PLCG1, one of the insulin-like growth factor-1 (IGF1) receptor downstream molecules |
|
upon T cell activation, LAT is phosphorylated and associates with GRB2, GRAP2, and PLCG1 through its four distal tyrosine residues |
|
CISH physically interacts with the TCR intermediate PLCG1, targeting it for proteasomal degradation after TCR stimulation |